Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Citado por Google
Similares en SciELO
Similares en Google
Compartir
Revista clínica de periodoncia, implantología y rehabilitación oral
versión On-line ISSN 0719-0107
Resumen
BRAVO, Joel et al. Clinical effect of Lactobacillus reuteri in the treatment of gingivitis: a randomized controlled clinical trial. Rev. Clin. Periodoncia Implantol. Rehabil. Oral [online]. 2018, vol.11, n.1, pp.32-35. ISSN 0719-0107. http://dx.doi.org/10.4067/S0719-01072018000100032.
Aim:
To evaluate the efficacy of L. reuteri as adjunct in the treatment of the gingivitis.
Materials and Methods:
A placebo-controlled clinical trial was conducted in gingivitis subjects for 3 months. Test treatment consisted of the administration of one tablet per day containing the probiotic strain Lactobacillus reuteri (doses 2x10(8) UFC per day), the control group received the same tablets but without live bacteria. The main outcome variable was the change in gingival index (GI), and the secondary outcome variables were the plaque index (PII) and the bleeding on probing (BoP). Outcome variables were compared between and within groups at baseline and at the end of intervention (3 months).
Results:
A total of 30 subjects (15 test, 15 control) were included in the analysis. No statistically significant differences were found between the groups at baseline (p> 0.05). Both treatment groups experienced a statistically significant improvement in the GI, PII and BoP (p < 0.05). There was a significant reduction in the number of sites with GI 2 only in the test group (p< 0.05).
Conclusions:
The use of probiotic tablets containing L. reuteri produces a significant reduction in the number of sites with severe inflammation.
Palabras clave : Gingival index; Gingivitis; Lactobacillus reuteri; Probiotics.